Abstract:Since the discovery of Neural Stem Cells (NSCs) there are still mechanism to be clarified, such as the role of mitochondrial metabolism in the regulation of endogenous adult neurogenesis and its implication in neurodegeneration. Although stem cells require glycolysis to maintain their stemness, they can perform oxidative phosphorylation and it is becoming more and more evident that mitochondria are central players, not only for ATP production but also for neuronal differentiation's steps regulation, through their ability to handle cellular redox state, intracellular signaling, epigenetic state of the cell, as well as the gut microbiota-brain axis, upon dietary influences. In this scenario, the 8-oxoguanine DNA glycosylase (OGG1) repair system would link mitochondrial DNA integrity to the modulation of neural differentiation. On the other side, there is an increasing interest in NSCs generation, from induced pluripotent stem cells, as a clinical model for neurodegenerative diseases (NDs), although this methodology still presents several drawbacks, mainly related to the reprogramming process. Indeed, high levels of reactive oxygen species (ROS), associated with telomere shortening, genomic instability, and defective mitochondrial dynamics, lead to pluripotency limitation and reprogramming efficiency's reduction. Moreover, while a physiological or moderate ROS increase serves as a signaling mechanism, to activate differentiation and suppress self-renewal, excessive oxidative stress is a common feature of NDs and aging. This ROS-dependent regulatory effect might be modulated by newly identified ROS suppressors, including the NAD+-dependent deacetylase enzymes family called Sirtuins (SIRTs). Recently, the importance of subcellular localization of NAD synthesis has been coupled to different roles for NAD in chromatin stability, DNA repair, circadian rhythms, and longevity. SIRTs have been described as involved in the control of both telomere's chromatin state and expression of nuclear gene involved in the regulation of mitochondrial gene expression, as well as in several NDs and aging. SIRTs are ubiquitously expressed in the mammalian brain, where they play important roles. In this review we summarize the current knowledge on how SIRTs-dependent modulation of mitochondrial metabolism could impact on neurogenesis and neurodegeneration, focusing mainly on ROS function and their role in SIRTs-mediated cell reprogramming and telomere protection.

Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators

SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases

The beneficial role of SIRT1 in preventive or therapeutic options of Neurodegenerative Diseases

Regulation of Mitophagy by Sirtuin Family Proteins: A Vital Role in Aging and Age-Related Diseases

Sirtuin Functions in the Brain: from Physiological to Pathological Aspects

Research progress on Sirtuins (SIRTs) family modulators

The role of sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective

Mitochondrial Sirtuins in cardiometabolic diseases.

Protective Effects and Mechanisms of Sirtuins in the Nervous System

Activation and inhibition of sirtuins: From bench to bedside

Mitochondrial Sirtuins in Parkinson’s Disease

The influential responsibility of sirtuins in senescence and associated diseases: A review

Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis

The Role of Protein S-Nitrosylation in Mitochondrial Quality Control in Central Nervous System Diseases

Targeting Mitochondrial Sirtuins in Age-Related Neurodegenerative Diseases and Fibrosis

Sirtuins and redox signaling interplay in neurogenesis, neurodegenerative diseases, and neural cell reprogramming

An overview of Sirtuins as potential therapeutic target: Structure, function and modulators

Role of Mitochondria in Neurodegenerative Diseases: from an Epigenetic Perspective

Sirtuins mediate mitochondrial quality control mechanisms: a novel therapeutic target for osteoporosis

A review on SIRT3 and its natural small molecule activators as a potential Preventive and therapeutic target

Regulatory Effects of NAD + Metabolic Pathways on Sirtuin Activity.